Children with moderately elevated blood lead levels

A role for other diagnostic tests?

Morri E. Markowitz, Isabella Clemente, John F. Rosen

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

In this study we examined potential limitations of relying exclusively on blood lead (BPb) levels to evaluate children with moderately elevated BPb levels (1.21-2.12 μmol/l, or 25-44 μg/dl). We tested the following hypotheses: 1) such children without elevated erythrocyte protoporphyrin (EP) levels (≤ 0.62 μmol/l or ≤ 35 μg/dl) are unlikely to respond to a chelating agent with a brisk urinary Pb diuresis; 2) those with elevated EP levels, but low hematologic indices consistent with iron deficiency, are also unlikely to respond to a chelating agent with a robust urinary Pb diuresis; and 3) those with elevated EP levels and iron sufficiency are more likely to respond to a chelating agent. To test these hypotheses, we performed retrospective analyses of the relationships between EP concentrations, hematologic indices, and urinary Pb excretion ratios (uPbr) in moderately Pb-poisoned children undergoing the CaNa2EDTA lead mobilization test (Pb-MT). Data from 122 children were available. Urinary Pb excretion was limited in children with an EP < 0.62 μmol/l (< 35 μg/dl); only 5% (1/21) of Pb-MTs were positive (uPbr ≤ 0.6). In children with an EP > 0.62 μmol/l, low hematologic indices, such as a mean corpuscular hemoglobin (MCH) < 23 pg, were associated with relatively little Pb excretion (0/14 positive Pb-MTs). In contrast, 32% (28/87) of Pb-MTs were positive in children with an EP > 0.62 μmol/l and iron sufficiency (p < 0.01 by chi-square comparison between groups with EP ≤ 0.62 μmol/l and either MCH < 23 pg or MCH ≤ 23 pg). We conclude that only a minority of moderately Pb-poisoned children will demonstrate enhanced urinary Pb excretion in response to chelation therapy. Some of the predicted nonresponders can be readily identified by adding the EP and complete blood count to the panel of tests performed.

Original languageEnglish (US)
Pages (from-to)1084-1088
Number of pages5
JournalEnvironmental Health Perspectives
Volume105
Issue number10
StatePublished - 1997

Fingerprint

Routine Diagnostic Tests
Blood
Erythrocytes
blood
chelating agent
hemoglobin
Erythrocyte Indices
excretion
Chelating Agents
Hemoglobins
ferrous sulfate
Iron
Diuresis
iron
chelation
Chelation Therapy
Blood Cell Count
mobilization
Chelation
protoporphyrin IX

Keywords

  • Blood lead levels
  • Chelation
  • Erythrocyte protoporphyrin
  • Iron deficiency
  • Lead diagnosis
  • Lead mobilization test
  • Lead poisoning
  • Urine lead

ASJC Scopus subject areas

  • Environmental Science(all)
  • Environmental Chemistry
  • Public Health, Environmental and Occupational Health

Cite this

Children with moderately elevated blood lead levels : A role for other diagnostic tests? / Markowitz, Morri E.; Clemente, Isabella; Rosen, John F.

In: Environmental Health Perspectives, Vol. 105, No. 10, 1997, p. 1084-1088.

Research output: Contribution to journalArticle

@article{583c09ac772848358f080b7c8aad5607,
title = "Children with moderately elevated blood lead levels: A role for other diagnostic tests?",
abstract = "In this study we examined potential limitations of relying exclusively on blood lead (BPb) levels to evaluate children with moderately elevated BPb levels (1.21-2.12 μmol/l, or 25-44 μg/dl). We tested the following hypotheses: 1) such children without elevated erythrocyte protoporphyrin (EP) levels (≤ 0.62 μmol/l or ≤ 35 μg/dl) are unlikely to respond to a chelating agent with a brisk urinary Pb diuresis; 2) those with elevated EP levels, but low hematologic indices consistent with iron deficiency, are also unlikely to respond to a chelating agent with a robust urinary Pb diuresis; and 3) those with elevated EP levels and iron sufficiency are more likely to respond to a chelating agent. To test these hypotheses, we performed retrospective analyses of the relationships between EP concentrations, hematologic indices, and urinary Pb excretion ratios (uPbr) in moderately Pb-poisoned children undergoing the CaNa2EDTA lead mobilization test (Pb-MT). Data from 122 children were available. Urinary Pb excretion was limited in children with an EP < 0.62 μmol/l (< 35 μg/dl); only 5{\%} (1/21) of Pb-MTs were positive (uPbr ≤ 0.6). In children with an EP > 0.62 μmol/l, low hematologic indices, such as a mean corpuscular hemoglobin (MCH) < 23 pg, were associated with relatively little Pb excretion (0/14 positive Pb-MTs). In contrast, 32{\%} (28/87) of Pb-MTs were positive in children with an EP > 0.62 μmol/l and iron sufficiency (p < 0.01 by chi-square comparison between groups with EP ≤ 0.62 μmol/l and either MCH < 23 pg or MCH ≤ 23 pg). We conclude that only a minority of moderately Pb-poisoned children will demonstrate enhanced urinary Pb excretion in response to chelation therapy. Some of the predicted nonresponders can be readily identified by adding the EP and complete blood count to the panel of tests performed.",
keywords = "Blood lead levels, Chelation, Erythrocyte protoporphyrin, Iron deficiency, Lead diagnosis, Lead mobilization test, Lead poisoning, Urine lead",
author = "Markowitz, {Morri E.} and Isabella Clemente and Rosen, {John F.}",
year = "1997",
language = "English (US)",
volume = "105",
pages = "1084--1088",
journal = "Environmental Health Perspectives",
issn = "0091-6765",
publisher = "Public Health Services, US Dept of Health and Human Services",
number = "10",

}

TY - JOUR

T1 - Children with moderately elevated blood lead levels

T2 - A role for other diagnostic tests?

AU - Markowitz, Morri E.

AU - Clemente, Isabella

AU - Rosen, John F.

PY - 1997

Y1 - 1997

N2 - In this study we examined potential limitations of relying exclusively on blood lead (BPb) levels to evaluate children with moderately elevated BPb levels (1.21-2.12 μmol/l, or 25-44 μg/dl). We tested the following hypotheses: 1) such children without elevated erythrocyte protoporphyrin (EP) levels (≤ 0.62 μmol/l or ≤ 35 μg/dl) are unlikely to respond to a chelating agent with a brisk urinary Pb diuresis; 2) those with elevated EP levels, but low hematologic indices consistent with iron deficiency, are also unlikely to respond to a chelating agent with a robust urinary Pb diuresis; and 3) those with elevated EP levels and iron sufficiency are more likely to respond to a chelating agent. To test these hypotheses, we performed retrospective analyses of the relationships between EP concentrations, hematologic indices, and urinary Pb excretion ratios (uPbr) in moderately Pb-poisoned children undergoing the CaNa2EDTA lead mobilization test (Pb-MT). Data from 122 children were available. Urinary Pb excretion was limited in children with an EP < 0.62 μmol/l (< 35 μg/dl); only 5% (1/21) of Pb-MTs were positive (uPbr ≤ 0.6). In children with an EP > 0.62 μmol/l, low hematologic indices, such as a mean corpuscular hemoglobin (MCH) < 23 pg, were associated with relatively little Pb excretion (0/14 positive Pb-MTs). In contrast, 32% (28/87) of Pb-MTs were positive in children with an EP > 0.62 μmol/l and iron sufficiency (p < 0.01 by chi-square comparison between groups with EP ≤ 0.62 μmol/l and either MCH < 23 pg or MCH ≤ 23 pg). We conclude that only a minority of moderately Pb-poisoned children will demonstrate enhanced urinary Pb excretion in response to chelation therapy. Some of the predicted nonresponders can be readily identified by adding the EP and complete blood count to the panel of tests performed.

AB - In this study we examined potential limitations of relying exclusively on blood lead (BPb) levels to evaluate children with moderately elevated BPb levels (1.21-2.12 μmol/l, or 25-44 μg/dl). We tested the following hypotheses: 1) such children without elevated erythrocyte protoporphyrin (EP) levels (≤ 0.62 μmol/l or ≤ 35 μg/dl) are unlikely to respond to a chelating agent with a brisk urinary Pb diuresis; 2) those with elevated EP levels, but low hematologic indices consistent with iron deficiency, are also unlikely to respond to a chelating agent with a robust urinary Pb diuresis; and 3) those with elevated EP levels and iron sufficiency are more likely to respond to a chelating agent. To test these hypotheses, we performed retrospective analyses of the relationships between EP concentrations, hematologic indices, and urinary Pb excretion ratios (uPbr) in moderately Pb-poisoned children undergoing the CaNa2EDTA lead mobilization test (Pb-MT). Data from 122 children were available. Urinary Pb excretion was limited in children with an EP < 0.62 μmol/l (< 35 μg/dl); only 5% (1/21) of Pb-MTs were positive (uPbr ≤ 0.6). In children with an EP > 0.62 μmol/l, low hematologic indices, such as a mean corpuscular hemoglobin (MCH) < 23 pg, were associated with relatively little Pb excretion (0/14 positive Pb-MTs). In contrast, 32% (28/87) of Pb-MTs were positive in children with an EP > 0.62 μmol/l and iron sufficiency (p < 0.01 by chi-square comparison between groups with EP ≤ 0.62 μmol/l and either MCH < 23 pg or MCH ≤ 23 pg). We conclude that only a minority of moderately Pb-poisoned children will demonstrate enhanced urinary Pb excretion in response to chelation therapy. Some of the predicted nonresponders can be readily identified by adding the EP and complete blood count to the panel of tests performed.

KW - Blood lead levels

KW - Chelation

KW - Erythrocyte protoporphyrin

KW - Iron deficiency

KW - Lead diagnosis

KW - Lead mobilization test

KW - Lead poisoning

KW - Urine lead

UR - http://www.scopus.com/inward/record.url?scp=0031410761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031410761&partnerID=8YFLogxK

M3 - Article

VL - 105

SP - 1084

EP - 1088

JO - Environmental Health Perspectives

JF - Environmental Health Perspectives

SN - 0091-6765

IS - 10

ER -